首页> 外文期刊>Human Molecular Genetics >A function retained by the common mutant CLN3 protein is responsible for the late onset of juvenile neuronal ceroid lipofuscinosis.
【24h】

A function retained by the common mutant CLN3 protein is responsible for the late onset of juvenile neuronal ceroid lipofuscinosis.

机译:常见突变体CLN3蛋白保留的功能是导致幼年神经元类固醇脂褐藻病晚期的原因。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The neuronal ceroid lipofuscinoses (NCLs) are common neurodegenerative disorders of childhood and are classified as lysosomal storage diseases since affected cells exhibit lysosomes containing ceroid and lipofuscin-like material. CLN3 is the most widely conserved NCL gene, suggesting that it has a basic eukaryotic cell function; its loss might be expected to cause the earliest onset and/or most severe disease. However, mutations in CLN3 are linked to juvenile NCL (JNCL), the latest onset and mildest form of NCL in children. We sought to explain this paradox. Almost all patients with JNCL are homozygous or heterozygous for an intragenic 1 kb deletion within CLN3, hitherto presumed to be a null mutation. We hypothesized that the 1 kb mutation may allow CLN3 residual function. We confirmed the presence of CLN3 transcripts in JNCL patient cells. When RNA silencing was used to deplete these transcripts in cells from JNCL patients, the lysosomes significantly increased in size, confirming the presence of functional protein in these cells. Consistently, overexpression of mutant CLN3 transcript caused lysosomes to decrease in size. We modelled the JNCL mutant transcripts and those corresponding to mouse models for Cln3 in Schizosaccharomyces pombe and confirmed that most transcripts retained significant function as we predicted. Therefore, we concluded that the common mutant CLN3 protein does indeed retain significant function and that JNCL is a mutation-specific disease phenotype. This finding has important consequences for recognition and diagnosis of disease caused by mutations in CLN3 and for the development of therapy for JNCL.
机译:神经元类固醇脂褐藻糖糖(NCL)是儿童期常见的神经退行性疾病,由于受影响的细胞显示出包含类固醇和脂褐质素样物质的溶酶体,因此被分类为溶酶体贮积病。 CLN3是最广泛保守的NCL基因,表明它具有基本的真核细胞功能。它的损失可能导致最早的发作和/或最严重的疾病。但是,CLN3中的突变与儿童NCL(JNCL)有关,后者是儿童中NCL的最新发作和最轻形式。我们试图解释这种悖论。迄今为止,几乎所有患有JNCL的患者都是纯合子或杂合子,因为CLN3内的基因内1 kb缺失被认为是无效突变。我们假设1 kb突变可能允许CLN3残留功能。我们确认在JNCL患者细胞中存在CLN3转录本。当使用RNA沉默来消耗JNCL患者细胞中的这些转录物时,溶酶体的大小显着增加,证实了这些细胞中功能蛋白的存在。一致地,突变型CLN3转录本的过表达导致溶酶体大小减小。我们对粟酒裂殖酵母中的JnCL突变体转录本和与Cln3小鼠模型相对应的那些进行了建模,并确认大多数转录本均保留了我们所预测的重要功能。因此,我们得出结论,常见的突变体CLN3蛋白确实确实保留了重要的功能,并且JNCL是一种突变特异性疾病表型。这一发现对于识别和诊断由CLN3突变引起的疾病以及开发JNCL疗法具有重要意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号